Biotech and Life Sciences

1+ hour, 14+ min ago   (68+ words) Aging has become a product. Across North America and Europe, companies now sell direct-to-consumer epigenetic tests that estimate a customer’s biological age from DNA methylation patterns, often bundled with supplements and lifestyle programs marketed as capable of slowing or even…...

2+ hour, 49+ min ago   (92+ words) This June, ten of the life sciences industry’s most respected board members came to New York for Accenture’s second annual Life Sciences Board Forum for something this industr... Ten life sciences board directors on AI's three hardest questions: developing the…...

8+ hour, 9+ min ago   (202+ words) Frazier Life Sciences has closed more than $1.1 billion in new capital commitments to its Public Fund, pushing the long-only investment vehicle's total committed capital to roughly $2.8 billion. The Palo Alto-based firm announced the raise Thursday, marking one of the largest…...

12+ hour, 31+ min ago   (610+ words) Pulmonary hypertension remains one of the most stubborn challenges in cardiovascular medicine, and a new study now points to an unexpected molecular player in the disease process....

1+ day, 15+ hour ago   (321+ words) Karyopharm bought an extra month to negotiate with creditors or pursue a deal. Elsewhere, BridgeBio Pharma’s oncology spinout shook up its development plans and a brain-focused gene therapy startup banked $275 million....

1+ day, 4+ hour ago   (86+ words) ...

1+ day, 1+ hour ago   (0+ words) ...

3+ day, 22+ hour ago   (811+ words) Moving artificial intelligence from experimentation into meaningful, production-scale applications is becoming increasingly important as life sciences organizations manage complex data, stringent regulations, and growing pressure to accelerate decision-making. Agilisium is helping address this need through a domain-oriented approach to agentic…...

1+ day, 16+ hour ago   (487+ words) As we age, blood stem cells, the essential source of new blood cells in the body, can accumulate genetic mutations. These mutations can give the cells a growth advantage, laying the foundation for developing serious health conditions. Now, scientists at…...

5+ day, 38+ min ago   (331+ words) The California biotech plans to bring its first drug, enabled by licensing technology from a Chinese drugmaker, into clinical testing for obesity by the end of 2027. When Moonwalk Biosciences launched in 2024, it set ambitious plans to mine the epigenome for…...